| Chirag R Jani, MD | |
|
427 W 3rd Ave, Albany, GA 31701-1975 | |
| (229) 312-5800 | |
| (229) 312-5853 |
| Full Name | Chirag R Jani |
|---|---|
| Gender | Male |
| Speciality | Hematology/oncology |
| Experience | 31 Years |
| Location | 427 W 3rd Ave, Albany, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477525624 | NPI | - | NPPES |
| 544247111A | Medicaid | GA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 052354 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Phoebe Putney Memorial Hospital | Albany, GA | Hospital |
| Phoebe Sumter Medical Center | Americus, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Phoebe Putney Memorial Hospital, Inc. | 4486559549 | 45 |
News Archive
Promega PowerPlex® 18D System is now approved for use in laboratories generating DNA records for the National DNA Index System (NDIS). NDIS is the U.S. national database containing over seven million offender and forensic DNA profiles used to help authorities identify criminals nationwide.
Georgia Health Sciences University, Augusta, GA exhibited a poster at the recent 11th National Conference on Cancer Nursing Research in Los Angeles, in which their clinical study showed RyMed Technologies' zero displacement InVision-Plus® IV Connector significantly decreased the incidence of catheter-related bloodstream infections (CR-BSIs) by 92.6% on average when compared to a simple split septum with negative displacement IV connector (Becton-Dickinson Q-Syte®) and a reversed split-septum device with negative displacement IV connector (ICU Medical Clave®).
Amgen today announced the initiation of the ARROW trial, a global Phase 3 study evaluating the benefit of Kyprolis® (carfilzomib) for Injection administered once-weekly with dexamethasone versus the current U.S. Food and Drug Administration (FDA) approved twice-weekly administration schedule in patients with relapsed and refractory multiple myeloma who have received prior treatment with bortezomib and an immunomodulatory agent (IMiD).
Professor Pilotto said that while previous research has shown a link between unflued gas exposure and asthma, the results of this study were more conclusive as they were based on a randomised control trial of unflued gas heater replacement.
For people trying to make a change in their diet, significant others generally play a positive and supportive role, but sometimes respond in negative ways, according to a study in the March/April Journal of Nutrition Education and Behavior ( http://www.jneb.org/ ).
› Verified 8 days ago
| Entity Name | Phoebe Putney Memorial Hospital, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992789721 PECOS PAC ID: 4486559549 Enrollment ID: O20031203000397 |
News Archive
Promega PowerPlex® 18D System is now approved for use in laboratories generating DNA records for the National DNA Index System (NDIS). NDIS is the U.S. national database containing over seven million offender and forensic DNA profiles used to help authorities identify criminals nationwide.
Georgia Health Sciences University, Augusta, GA exhibited a poster at the recent 11th National Conference on Cancer Nursing Research in Los Angeles, in which their clinical study showed RyMed Technologies' zero displacement InVision-Plus® IV Connector significantly decreased the incidence of catheter-related bloodstream infections (CR-BSIs) by 92.6% on average when compared to a simple split septum with negative displacement IV connector (Becton-Dickinson Q-Syte®) and a reversed split-septum device with negative displacement IV connector (ICU Medical Clave®).
Amgen today announced the initiation of the ARROW trial, a global Phase 3 study evaluating the benefit of Kyprolis® (carfilzomib) for Injection administered once-weekly with dexamethasone versus the current U.S. Food and Drug Administration (FDA) approved twice-weekly administration schedule in patients with relapsed and refractory multiple myeloma who have received prior treatment with bortezomib and an immunomodulatory agent (IMiD).
Professor Pilotto said that while previous research has shown a link between unflued gas exposure and asthma, the results of this study were more conclusive as they were based on a randomised control trial of unflued gas heater replacement.
For people trying to make a change in their diet, significant others generally play a positive and supportive role, but sometimes respond in negative ways, according to a study in the March/April Journal of Nutrition Education and Behavior ( http://www.jneb.org/ ).
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Chirag R Jani, MD 427 W 3rd Ave, Albany, GA 31701-1975 Ph: (229) 312-5800 | Chirag R Jani, MD 427 W 3rd Ave, Albany, GA 31701-1975 Ph: (229) 312-5800 |
News Archive
Promega PowerPlex® 18D System is now approved for use in laboratories generating DNA records for the National DNA Index System (NDIS). NDIS is the U.S. national database containing over seven million offender and forensic DNA profiles used to help authorities identify criminals nationwide.
Georgia Health Sciences University, Augusta, GA exhibited a poster at the recent 11th National Conference on Cancer Nursing Research in Los Angeles, in which their clinical study showed RyMed Technologies' zero displacement InVision-Plus® IV Connector significantly decreased the incidence of catheter-related bloodstream infections (CR-BSIs) by 92.6% on average when compared to a simple split septum with negative displacement IV connector (Becton-Dickinson Q-Syte®) and a reversed split-septum device with negative displacement IV connector (ICU Medical Clave®).
Amgen today announced the initiation of the ARROW trial, a global Phase 3 study evaluating the benefit of Kyprolis® (carfilzomib) for Injection administered once-weekly with dexamethasone versus the current U.S. Food and Drug Administration (FDA) approved twice-weekly administration schedule in patients with relapsed and refractory multiple myeloma who have received prior treatment with bortezomib and an immunomodulatory agent (IMiD).
Professor Pilotto said that while previous research has shown a link between unflued gas exposure and asthma, the results of this study were more conclusive as they were based on a randomised control trial of unflued gas heater replacement.
For people trying to make a change in their diet, significant others generally play a positive and supportive role, but sometimes respond in negative ways, according to a study in the March/April Journal of Nutrition Education and Behavior ( http://www.jneb.org/ ).
› Verified 8 days ago
Dr. Noelle Alicia Rolle, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 417 W 3rd Ave, Albany, GA 31701 Phone: 229-312-1000 | |
Dr. Michael Walter Szpak, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 1009 N Monroe St, Albany, GA 31701 Phone: 229-883-0298 Fax: 229-438-7898 | |
Robyn Mann Johnson, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1712-a East Broad Avenue, Albany, GA 31705 Phone: 229-639-3100 Fax: 229-888-6516 | |
Kuo-kang Fang, M. D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 522 5th Ave, Albany, GA 31701 Phone: 229-888-6811 Fax: 229-888-6812 | |
Phillip Poulos, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2202 E Oglethorpe Blvd, Albany, GA 31705 Phone: 229-431-1423 | |
Daniel Adam Jones, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 425 W 3rd Ave Ste 50, Albany, GA 31701 Phone: 229-883-0717 Fax: 229-312-2265 | |
Jeffrey L Bell, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1200 N Jefferson St, Albany, GA 31701 Phone: 229-888-3970 Fax: 229-889-9386 |